Electrophilic fragment-based design of reversible covalent kinase inhibitors.
Miller, R.M., Paavilainen, V.O., Krishnan, S., Serafimova, I.M., Taunton, J.(2013) J Am Chem Soc 135: 5298-5301
- PubMed: 23540679 
- DOI: 10.1021/ja401221b
- Primary Citation of Related Structures:  
4JG6, 4JG7, 4JG8 - PubMed Abstract: 
Fragment-based ligand design and covalent targeting of noncatalytic cysteines have been employed to develop potent and selective kinase inhibitors. Here, we combine these approaches, starting with a panel of low-molecular-weight, heteroaryl-susbstituted cyanoacrylamides, which we have previously shown to form reversible covalent bonds with cysteine thiols ...